Molecular detection of the BCR-ABL1 fusion transcripts is necessary for the genetic confirmation of a chronic myeloid leukemia diagnosis and for the risk classification of acute lymphoblastic leukemia. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.